HEALTHCARE TRUST OF AME-CL A (HTA)

US42225P5017 - REIT

29.19  -0.02 (-0.07%)

After market: 29.23 +0.04 (+0.14%)

Fundamental Rating

2

Overall HTA gets a fundamental rating of 2 out of 10. We evaluated HTA against 127 industry peers in the Diversified REITs industry. Both the profitability and financial health of HTA have multiple concerns. HTA is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year HTA was profitable.
In the past 5 years HTA has always been profitable.
In the past 5 years HTA always reported a positive cash flow from operatings.

1.2 Ratios

Industry RankSector Rank
ROA 1.38%
ROE 2.94%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 23.13%
PM (TTM) 12.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

HTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HTA has been increased compared to 1 year ago.
Compared to 1 year ago, HTA has an improved debt to assets ratio.

2.2 Solvency

A Debt/Equity ratio of 0.95 indicates that HTA is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.43%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.54% over the past year.
Measured over the past 5 years, HTA shows a small growth in Earnings Per Share. The EPS has been growing by 6.58% on average per year.
HTA shows a small growth in Revenue. In the last year, the Revenue has grown by 4.43%.
HTA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.72% yearly.
EPS 1Y (TTM)61.54%
EPS 3Y25.99%
EPS 5Y6.58%
EPS growth Q2Q-20%
Revenue 1Y (TTM)4.43%
Revenue growth 3Y3.27%
Revenue growth 5Y10.72%
Revenue growth Q2Q5.48%

3.2 Future

The Earnings Per Share is expected to grow by 9.57% on average over the next years. This is quite good.
Based on estimates for the next years, HTA will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y-3.59%
EPS Next 2Y3.13%
EPS Next 3Y7.42%
EPS Next 5Y9.57%
Revenue Next Year6.57%
Revenue Next 2Y4.52%
Revenue Next 3Y4.63%
Revenue Next 5Y4.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 69.50 indicates a quite expensive valuation of HTA.
HTA is valuated expensively when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 62.38, the valuation of HTA can be described as expensive.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.41, HTA is valued quite expensively.
Industry RankSector Rank
PE 69.5
Fwd PE 62.38

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)10.57
EPS Next 2Y3.13%
EPS Next 3Y7.42%

1

5. Dividend

5.1 Amount

HTA has a yearly dividend return of 0.40%, which is pretty low.
With a Dividend Yield of 0.40, HTA pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.4%

5.2 History

HTA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

303.50% of the earnings are spent on dividend by HTA. This is not a sustainable payout ratio.
DP303.5%
EPS Next 2Y3.13%
EPS Next 3Y7.42%

HEALTHCARE TRUST OF AME-CL A

NYSE:HTA (7/20/2022, 7:04:00 PM)

After market: 29.23 +0.04 (+0.14%)

29.19

-0.02 (-0.07%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.69B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.4%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 69.5
Fwd PE 62.38
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)10.57
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.94%
ROCE
ROIC
ROICexc
ROICexgc
OM 23.13%
PM (TTM) 12.13%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)61.54%
EPS 3Y25.99%
EPS 5Y
EPS growth Q2Q
EPS Next Y-3.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.43%
Revenue growth 3Y3.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y